Ideaya Biosciences
IPOImproving lives through transformative precision medicines
Public · South San Francisco, United States · Founded 2015
- Headquarters
- South San Francisco, California
- Employees
- 201–500
- Founded
- 2015
- Business Model
- B2B
- Website
- ideayabio.com
- Type
- Public
About
IDEAYA Biosciences is a precision medicine oncology company committed to the discovery, development, and commercialization of transformative therapies for cancer. The company targets hidden tumor vulnerabilities through synthetic lethality, metabolic and epigenetic dependencies, and other precision oncology approaches designed to overcome tumor growth and drug resistance. Its pipeline includes PKC inhibition in uveal melanoma, TOP1 ADC and DNA-damage-response combinations, MTAP-pathway programs for MTAP-deleted cancers, and KAT6/7 epigenetic inhibitors, with clinical trials focused on patients who have limited treatment options.
Summary
Ideaya Biosciences is a Biotech company based in South San Francisco, United States, founded in 2015.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ideaya-biosciences"><img src="https://indexed.vc/api/badge/company/ideaya-biosciences" alt="Ideaya Biosciences on Indexed.vc" width="260" height="76" /></a>
